Combo of Nicotine Patches and Chantix Is Likely To Increase Quit Smoking Chances Over Short Term
Date: 8th July 2014
The results derived from a latest study have shown that if the quit smoking medication Chantix and nicotine patches are used in combination, then it will definitely improve the chances of smoking cessation over short term period. Dr. Coenie Koegelenberg, who is an associate professor of pulmonology with Stellenbosch University and Tygerberg Academic Hospital in South Africa, states that the combination seems to be safe but additional studies are required to verify this.
Researchers carried out the study by making 446 smokers, comprised mostly of women, use Chantix and a nicotine patch or the nicotine patch with a placebo. The researchers continued the treatment procedure for a period of 14 weeks. As the study continued, at 12 weeks, it became evident that in comparison to 41 percent smokers who received the placebo, 55 percent smokers taking both Chantix and the nicotine patch had quit smoking. Then, after a period of six months, the quit smoking numbers were 33 percent and 49 percent, correspondingly.
Regarding side effects, it is noteworthy that the group receiving both Chantix and nicotine patch treatments had more depression, constipation, skin reactions, insomnia and nausea than those who used the nicotine patch alone. But according to the researchers, only skin reactions were more considerable. The double-treatment group suffered from 14% skin reactions while those were only 8% in the placebo group.
The study was funded by McNeil and Pfizer, the manufacturers of nicotine patches and Chantix. Further, it is noteworthy that the study will be published in the 9th July issue of the Journal of the American Medical Association.